 MrMed Partners with Eli Lilly to Expand Access to Affordable GLP-1 Medications in IndiaBy: MrMed.in India faces a severe healthcare crisis with over 100 million people affected by diabetes and obesity. Rising treatment costs force families to exhaust savings and borrow at high rates. Many advanced therapies remain financially out of reach for patients who need them most. The partnership between MrMed and Eli Lilly addresses this critical gap by making life-saving GLP-1 medications available at affordable prices. By eliminating intermediaries and sourcing directly from manufacturers, MrMed reduces the markup that traditionally adds unnecessary burden to struggling families. "Our partnership with Eli Lilly enables us to reach more patients with life-saving GLP-1 therapies at prices they can afford," said Devashish Singh, Co-Founder & CEO of MrMed. The collaboration ensures patients receive genuine, quality medications through transparent pricing and reliable delivery. To support this partnership, MrMed has launched a state-of-the- "We're committed to making advanced diabetes and obesity treatments accessible nationwide," About MrMed MrMed is India's largest online specialty pharmacy, dedicated to making high-cost medicines accessible and affordable. The company provides genuine products, specialist counseling, and reliable cold-chain delivery to patients across therapeutic areas nationwide. Company: MrMed.in Website: https://www.mrmed.in/ App: https://onelink.to/ Address: No. 5 (3), Ground Floor, Raja Street, T-Nagar, Chennai - 600017 (India) Phone: +91-8939169999 End
|
|
Account Phone Number